Drug Industry – Page 11

Pharma’s Future at Stake: Trump’s Victory and Its Implications for Drug Pricing Reform

10 months ago talkbio0Tagged 2024, Biopharma, Donald Trump, Drug Industry, Drug Pricing Reform, Inflation, Kamala Harris, Mediation, Medicare, presidential election, Prices

Donald Trump, Kamala Harris, 2024 Presidential Election, Drug Pricing Reform, Inflation Reduction Act, Medicare Price Negotiations, Pharmaceutical Industry, Biopharma.

Bristol Myers Squibb Posts Strong Q3 Results, Boosts 2024 Guidance on Robust Sales of Legacy and New Drugs

10 months ago talkbio0Tagged Advice, Drug Industry, earnings, financial performance, Inheritance, Myers, squibb

Bristol Myers Squibb, Q3 earnings, 2024 guidance, legacy drugs, newer drugs, pharmaceutical industry, financial performance

Biogen Raises Profit Guidance Amid Leqembi Growth and MS Sales Decline

10 months ago talkbio0Tagged Biogen, Drug Industry, earnings, Leqembi, Multiple Sclerosis, profit, Report (document)

Biogen, profit guidance, Leqembi, multiple sclerosis, earnings report, pharmaceutical industry

Biotech Layoffs Continue in 2024: Spero and Pfizer Among Latest to Cut Workforce

10 months ago talkbio0Tagged Biotech Layoffs, Drug Industry, layoffs, Pfizer, Spero

Biotech layoffs, Spero, Pfizer, workforce reduction, 2024 layoffs, pharmaceutical industry, job cuts.

WuXi AppTec Continues to Attract New Clients Amid BIOSECURE Act Uncertainty

10 months ago talkbio0Tagged AppTec, BIOSECURE, chain vulnerabilities, Chinese, Chinese contract manufacturer, Clients, Drug Industry, Senate consideration, WuXi

WuXi AppTec, BIOSECURE Act, new clients, revenue decline, Chinese contract manufacturer, U.S. Senate consideration, pharmaceutical industry, supply chain vulnerabilities.